TERN
USDTerns Pharmaceuticals Inc. Common Stock
リアルタイム価格
価格チャート
主要指標
市場指標
始値
$15.500
高値
$18.740
安値
$15.500
出来高
4.37M
企業ファンダメンタルズ
時価総額
1.5B
業種
バイオテクノロジー
国
United States
取引統計
平均出来高
1.85M
取引所
NMS
通貨
USD
52週レンジ
関連ニュース
Truist Securities Reiterates Buy on Terns Pharma, Raises Price Target to $28
Truist Securities analyst Srikripa Devarakonda reiterates Terns Pharma with a Buy and raises the price target from $20 to $28.
BMO Capital Maintains Outperform on Terns Pharma, Raises Price Target to $22
BMO Capital analyst Etzer Darout maintains Terns Pharma with a Outperform and raises the price target from $15 to $22.
Barclays Maintains Overweight on Terns Pharma, Raises Price Target to $27
Barclays analyst Etzer Darout maintains Terns Pharma with a Overweight and raises the price target from $14 to $27.
HC Wainwright & Co. Upgrades Terns Pharma to Buy, Announces $20 Price Target
HC Wainwright & Co. analyst Andres Y. Maldonado upgrades Terns Pharma from Neutral to Buy and announces $20 price target.
William Blair Upgrades Terns Pharma to Outperform
William Blair analyst Andy Hsieh upgrades Terns Pharma from Market Perform to Outperform.
Terns Pharmaceuticals' Leukemia Drug Seen As Potential Disruptor In CML Treatment Landscape, Analyst Upgrades
Terns Pharmaceuticals shares rise after TERN-701 shows a 75% response rate in the CML trial, and William Blair upgrades the stock to Outperform.
Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annual Meeting
Unprecedented Phase 1 CML efficacy data with 64% MMR achievement by 24 weeks in a refractory patient population Encouraging safety and tolerability profile at all doses evaluated Company to host investor update call on
